Literature DB >> 25486519

Prosthetic Valve Thrombosis: Diagnosis and Management.

Jalaj Garg1, Chandrasekar Palaniswamy, Sowmya Pinnamaneni, Judy Sarungbam, Diwakar Jain.   

Abstract

St. Jude mechanical prosthesis is the most commonly used prosthetic device with least valvular complications with excellent hemodynamics. However, prosthetic valve thrombosis is one of the serious complications, with rates between 0.03% and 0.13% per patient-year depending on the type of anticoagulation used and compliance to the therapy. Transthoracic echocardiography (TTE) is the initial screening tool (class I) that would provide clues for the assessment of valvular hemodynamics. Fluoroscopy is an alternate imaging modality for the assessment of mechanical leaflet motion, especially in patients when prosthetic valves are difficult to image on TTE or transesophageal echocardiography. A complete fluoroscopic evaluation of a prosthetic valve includes assessment of valvular motion and structural integrity. Opening and closing angles can be measured fluoroscopically to determine whether a specific valve is functioning properly. We discuss a case of a 91-year-old man with thrombosis of bileaflet mechanical mitral prosthesis that was demonstrated on real-time fluoroscopy (not evident on TTE). An algorithmic approach to diagnosis and management of prosthetic heart valve thrombosis is outlined.

Entities:  

Mesh:

Year:  2016        PMID: 25486519     DOI: 10.1097/MJT.0000000000000117

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  2 in total

1.  Treatment of Recurrent Prosthetic Mitral Valve Thrombosis with Reteplase: A Report of Four Cases.

Authors:  Neda Behzadnia; Babak Sharif Kashani; Arda Kiani; Atefe Abedini; Seyed Reza Seyedi; Hossein Zargham Ahmadi; Farah Naghash Zadeh; Atefeh Fakharian
Journal:  Tanaffos       Date:  2016

2.  Thrombolytic treatment of prosthetic valve thrombosis: a study using Urokinase.

Authors:  Feng Huang; Yongrong Lan; Zhangbo Cheng; Zili Zhang; Fei Ren
Journal:  J Cardiothorac Surg       Date:  2020-10-01       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.